169 related articles for article (PubMed ID: 20930564)
1. Proteomic consequences of expression and pathological conversion of the prion protein in inducible neuroblastoma N2a cells.
Provansal M; Roche S; Pastore M; Casanova D; Belondrade M; Alais S; Leblanc P; Windl O; Lehmann S
Prion; 2010; 4(4):292-301. PubMed ID: 20930564
[TBL] [Abstract][Full Text] [Related]
2. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles.
Alais S; Simoes S; Baas D; Lehmann S; Raposo G; Darlix JL; Leblanc P
Biol Cell; 2008 Oct; 100(10):603-15. PubMed ID: 18422484
[TBL] [Abstract][Full Text] [Related]
3. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
4. Prion-protein-specific aptamer reduces PrPSc formation.
Proske D; Gilch S; Wopfner F; Schätzl HM; Winnacker EL; Famulok M
Chembiochem; 2002 Aug; 3(8):717-25. PubMed ID: 12203970
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of quality control proteins reduces prion conversion in prion-infected cells.
Thapa S; Abdulrahman B; Abdelaziz DH; Lu L; Ben Aissa M; Schatzl HM
J Biol Chem; 2018 Oct; 293(41):16069-16082. PubMed ID: 30154245
[TBL] [Abstract][Full Text] [Related]
6. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
[TBL] [Abstract][Full Text] [Related]
7. Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrP
Taguchi Y; Lu L; Marrero-Winkens C; Otaki H; Nishida N; Schatzl HM
J Biol Chem; 2018 Aug; 293(33):12730-12740. PubMed ID: 29934306
[TBL] [Abstract][Full Text] [Related]
8. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
[TBL] [Abstract][Full Text] [Related]
9. Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro.
Vorberg I; Raines A; Priola SA
J Biol Chem; 2004 Jul; 279(28):29218-25. PubMed ID: 15133048
[TBL] [Abstract][Full Text] [Related]
10. Characterization of prion susceptibility in Neuro2a mouse neuroblastoma cell subclones.
Uryu M; Karino A; Kamihara Y; Horiuchi M
Microbiol Immunol; 2007; 51(7):661-9. PubMed ID: 17641468
[TBL] [Abstract][Full Text] [Related]
11. Styryl-based and tricyclic compounds as potential anti-prion agents.
Chung E; Prelli F; Dealler S; Lee WS; Chang YT; Wisniewski T
PLoS One; 2011; 6(9):e24844. PubMed ID: 21931860
[TBL] [Abstract][Full Text] [Related]
12. Pathologic prion protein infects cells by lipid-raft dependent macropinocytosis.
Wadia JS; Schaller M; Williamson RA; Dowdy SF
PLoS One; 2008; 3(10):e3314. PubMed ID: 19390657
[TBL] [Abstract][Full Text] [Related]
13. Prion protein complexed to N2a cellular RNAs through its N-terminal domain forms aggregates and is toxic to murine neuroblastoma cells.
Gomes MP; Millen TA; Ferreira PS; e Silva NL; Vieira TC; Almeida MS; Silva JL; Cordeiro Y
J Biol Chem; 2008 Jul; 283(28):19616-25. PubMed ID: 18456654
[TBL] [Abstract][Full Text] [Related]
14. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation.
Norstrom EM; Mastrianni JA
J Biol Chem; 2005 Jul; 280(29):27236-43. PubMed ID: 15917252
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells.
Kumar R; McClain D; Young R; Carlson GA
J Gen Virol; 2008 Jun; 89(Pt 6):1525-1532. PubMed ID: 18474570
[TBL] [Abstract][Full Text] [Related]
16. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
17. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
[TBL] [Abstract][Full Text] [Related]
18. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion.
Rigter A; Bossers A
J Gen Virol; 2005 Sep; 86(Pt 9):2627-2634. PubMed ID: 16099922
[TBL] [Abstract][Full Text] [Related]
19. An astrocyte cell line that differentially propagates murine prions.
Tahir W; Abdulrahman B; Abdelaziz DH; Thapa S; Walia R; Schätzl HM
J Biol Chem; 2020 Aug; 295(33):11572-11583. PubMed ID: 32561641
[TBL] [Abstract][Full Text] [Related]
20. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]